Virtus Investment Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtus Investment Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	318,598 +242,429	+318%	+$934K	0.31%	146
2026 Q1	$267K	Buy	76,169 +1,858	+3%	+$7.62K	0.07%	299
2025 Q4	$250K	Buy	+74,311	New	+$193K	0.07%	333
2025 Q2	–	Sell	-100,851	Closed	-$148K	–	468
2025 Q1	$148K	Buy	+100,851	New	+$240K	0.04%	336
2024 Q2	–	Sell	-21,173	Closed	-$184K	–	358
2024 Q1	$184K	Hold	21,173	–	–	0.13%	199
2023 Q4	$242K	Hold	21,173	–	–	0.18%	156
2023 Q3	$204K	Hold	21,173	–	–	0.14%	174
2023 Q2	$225K	Buy	+21,173	New	+$228K	0.15%	173

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Virtus Investment Advisers's IRWD Position: Q2 2026 in Review

Virtus Investment Advisers increased its Ironwood Pharmaceuticals (IRWD) stake by 318% in Q2 2026, buying an estimated $934K and bringing the position to 318,598 shares worth $1.34M. The position accounts for 0.31% of the portfolio, ranked #146.

Virtus Investment Advisers first reported a position in IRWD in Q2 2023 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Virtus Investment Advisers held 318,598 shares of Ironwood Pharmaceuticals worth $1.34M as of Q2 2026.
Virtus Investment Advisers bought 242,429 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $934K.
Ironwood Pharmaceuticals made up 0.31% of Virtus Investment Advisers's portfolio in Q2 2026, its #146 holding.
Virtus Investment Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.